{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:22Z","timestamp":1761895282037,"version":"3.38.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ijrobp.2010.09.044","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T01:42:48Z","timestamp":1305942168000},"page":"1122-1127","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes of Patients With Non-Hodgkin's Lymphoma Treated With Bexxar With or Without External-Beam Radiotherapy"],"prefix":"10.1016","volume":"82","clinical-trial-number":[{"clinical-trial-number":"nct00271050","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00490490","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kristy","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gracie","family":"Byer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Lightsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.09.044_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","article-title":"Follicular lymphoma: Prognostic factors for response and survival","volume":"4","author":"Gallagher","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","article-title":"Patterns of survival in patients with recurrent follicular lymphoma: A 20-year study from a single center","volume":"13","author":"Johnson","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib4","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2001.19.19.3918","article-title":"Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin\u2019s lymphomas","volume":"19","author":"Kaminski","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","article-title":"131I-tositumomab therapy as initial treatment for follicular lymphoma","volume":"352","author":"Kaminski","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1200\/JCO.2005.07.040","article-title":"Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab","volume":"23","author":"Horning","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijrobp.2005.01.017","article-title":"Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy","volume":"63","author":"Gokhale","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","article-title":"Long-term results with radiotherapy for stage I-II follicular lymphomas","volume":"51","author":"Wilder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0360-3016(99)00051-6","article-title":"The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin\u2019s lymphoma","volume":"44","author":"Kamath","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(96)00631-1","article-title":"Is comprehensive lymphatic irradiation for low-grade non-Hodgkin\u2019s lymphoma curative therapy? Long-term experience at a single institution","volume":"38","author":"De Los Santos","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(01)00107-X","article-title":"Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma","volume":"39","author":"Wiseman","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"MacManus","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/02841860310014435","article-title":"A systematic overview of radiation therapy effects in non-Hodgkin\u2019s lymphoma","volume":"42","author":"Gustavsson","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/02841860310013346","article-title":"A systematic overview of radiation therapy effects in Hodgkin\u2019s lymphoma","volume":"42","author":"Gustavsson","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib15","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: A population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib16","first-page":"7022","article-title":"Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure","volume":"48","author":"Jain","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib17","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: A new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables\u2014series B (methodological)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib20","unstructured":"Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0. Available at: http:\/\/ctep.info.nih.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accesssed June 3rd, 2010."},{"key":"10.1016\/j.ijrobp.2010.09.044_bib21","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1200\/JCO.2004.00.9217","article-title":"Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin\u2019s lymphomas","volume":"23","author":"Fisher","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/annonc\/mdq024","article-title":"FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: Multicentric study","volume":"21","author":"Lopci","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib23","first-page":"285","article-title":"Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer","volume":"9","author":"Yu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib24","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","article-title":"Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma","volume":"26","author":"Morschhauser","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/COC.0b013e318187ddbb","article-title":"Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer\u2019s ring","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","article-title":"Treatment of non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: Radiotherapy versus chemotherapy versus combined therapy","volume":"32B","author":"Aviles","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2009.12.030","article-title":"External beam radiotherapy followed by (90)Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma","volume":"79","author":"Burdick","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.ijrobp.2010.09.044_bib28","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1040-8428(01)00127-5","article-title":"[18F]-FDG positron imaging in clinical management of lymphoma patients","volume":"38","author":"Talbot","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"Wohrer","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin\u2019s lymphoma (NHL)","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11307-009-0200-9","article-title":"Comparison of CT, PET, and PET\/CT for staging of patients with indolent non-Hodgkin\u2019s lymphoma","volume":"11","author":"Fueger","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.ijrobp.2010.09.044_bib33","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.2009.26.8748","article-title":"Radioimmunotherapy of lymphoma: A treatment approach ahead of its time or past its sell-by date?","volume":"28","author":"Illidge","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610033535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610033535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:34:21Z","timestamp":1741199661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610033535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0360301610033535"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.044","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}